ICD-10

ICD-10 code P50-P61

You are here: Home > ICD-10-CM > P00-P96

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- P00-P96
Certain conditions originating in the perinatal period

P50-P61

Hemorrhagic and hematological disorders of newborn

ICD-10 code P50-P61 for Hemorrhagic and hematological disorders of newborn

Excludes1: congenital stenosis and stricture of bile ducts (Q44.3)
Crigler-Najjar syndrome (E80.5)
Dubin-Johnson syndrome (E80.6)
Gilbert syndrome (E80.4)
hereditary hemolytic anemias (D55-D58)
P50
Newborn affected by intrauterine (fetal) blood loss
P51
Umbilical hemorrhage of newborn
P52
Intracranial nontraumatic hemorrhage of newborn
P53
Hemorrhagic disease of newborn
P54
Other neonatal hemorrhages
P55
Hemolytic disease of newborn
P56
Hydrops fetalis due to hemolytic disease
P57
Kernicterus
P58
Neonatal jaundice due to other excessive hemolysis
P59
Neonatal jaundice from other and unspecified causes
P60
Disseminated intravascular coagulation of newborn
P61
Other perinatal hematological disorders
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us